genOway SA ALGEN

EURONEXT · France · Health Technology

€2.25-0.09 (-3.85%)

Market closed· Oct 1, 2026, 3:13 PM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

genOway SA ALGEN

EURONEXT · France · Health Technology

€2.25-0.09 (-3.85%)

Market closed· Oct 1, 2026, 3:13 PM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-10.71% · 6MFull-screen chart

Open €2.32High €2.34Low €2.19Close €2.25Volume 8.57K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: €2.34
Day range: €2.19 – €2.34
52-week range: €2.10 – €3.07
Volume: 8.57K
Market cap: €29.11M
P/E (last fiscal year): 29.3
Avg. volume (1Y): 7.01K

Performance

1 week

-6.25%

1 month

-8.54%

3 months

-6.64%

6 months

-8.91%

Year to date

-16.67%

1 year

-23.99%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: France
Exchange: EURONEXT
Shares outstanding: 12.34M
Employees: 157
ISIN: FR0004053510
Beta: 0.50

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceMay 14, 2026

[Latest] Global Transgenic Animals Market Size/Share Worth USD 7.89 Billion by 2035 at a 10.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Transgenic Animals Market size & share revenue was valued at approximately USD 3.42 Billion in 2025 and is expected to reach USD 3.76 Billion in 2026 and is expected to reach around USD 7.89 Billion by 2035, at a CAGR of 10.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are The Jackson Laboratory, Charle

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.